Skip to content

Drug interactions

Canakinumab + Ustekinumab

Severity: Major

Canakinumab and Ustekinumab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both are biologic cytokine inhibitors that raise infection risk. Used together, the risk of serious infection may be higher, and with canakinumab there is evidence of more infections when combined with other immunosuppressants.

What this interaction means in plain words

Canakinumab and Ustekinumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Canakinumab belongs to Miscellaneous; Ustekinumab belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Additive immunosuppression: IL-1β blockade plus IL-12/IL-23 blockade.

What to do

Avoid combining unless clearly necessary. If used together, monitor for infection and stop for serious infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Canakinumab and Ustekinumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Canakinumab with Ustekinumab?

MediHelp rates the interaction as major. Canakinumab and Ustekinumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both are biologic cytokine inhibitors that raise infection risk. Used together, the risk of serious infection may be higher, and with canakinumab there is evidence of more infections when combined with other immunosuppressants.

How serious is the interaction between Canakinumab and Ustekinumab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining unless clearly necessary. If used together, monitor for infection and stop for serious infection.

What other medicines interact with Ustekinumab?

MediHelp also lists interactions of Ustekinumab with, for example, Bcg vaccine live, Typhoid vaccine live, Adalimumab. The full list is on the Ustekinumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in